Wallac Oy
3 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 3 name spellings.
11
Ending by 2030
Nov 2026
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Apr 15, 2027The maintenance fee for Method for determining the risk of preterm birth (US 10,444,247) comes due Apr 15, 2027. Unpaid by Oct 15, 2027, it lapses early.
- 1 fee due Aug 2, 2027The maintenance fee for Methods for determining maternal health risks (US 9,250,251) comes due Aug 2, 2027. Unpaid by Feb 2, 2028, it lapses early.
- 1 fee due Nov 3, 2027The maintenance fee for Method and apparatus for detecting elution of samples (US 9,329,120) comes due Nov 3, 2027. Unpaid by May 3, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,625,930 | Chelating agents and highly luminescent and stable chelates and their use In force · From the USPTO record | In force | From the USPTO record | |
| US 8,012,101 | Punching tool for taking biological samples In force · From the USPTO record | In force | From the USPTO record | |
| US 8,221,719 | Luminescent lanthanide (III) chelates, chelating agents and conjugates derived thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 8,673,582 | Methods for determining the risk of prenatal complications In force · From the USPTO record | In force | From the USPTO record | |
| US 8,932,823 | Methods for determining the risk of prenatal complications In force · From the USPTO record | In force | From the USPTO record | |
| US 8,374,418 | Method and apparatus relating to sample card punching In force · From the USPTO record | In force | From the USPTO record | |
| US 9,885,700 | Method and apparatus for detecting elution of samples In force · From the USPTO record | In force | From the USPTO record | |
| US 8,597,903 | Biotinidase assay In force · From the USPTO record | In force | From the USPTO record | |
| US 8,647,832 | Methods for determining the risk of prenatal complications In force · From the USPTO record | In force | From the USPTO record | |
| US 8,759,789 | Body module for an optical measurement instrument In force · From the USPTO record | In force | From the USPTO record |
Also on record, not counted in the 35: 3 patents in force now held by others · 21 lapsed for an unpaid fee · 81 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
2 pending · 29 no status recorded